Qigong and Multicomponent Exercise in Panic Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorDokuz Eylul University

About this trial

Panic disorder is a psychiatric disease characterized by recurrent panic attacks that occur in expected or unexpected situations and create feelings of intense fear, restlessness and discomfort. Panic disorder often has a chronic course, its frequency and severity can be irregular, various physical, mental, and behavioral symptoms can develop, and the quality of life of individuals can decrease significantly. Evidence-based psychotherapy and pharmacotherapy are effective in reducing the symptoms of panic disorder and managing the disorder. However, both of these treatment methods have certain limitations, and approximately one-third of patients do not respond to therapy or the response is not sufficiently effective. Delaying treatment of the disease results in a poor prognosis and more established symptoms. Exercise can be viewed as a low-cost, supportive treatment for relieving symptoms with comparable efficacy to medication and other psychological interventions. Although exercise is recommended for patients with anxiety-panic disorder, there remains uncertainty about whether its effects are sustainable, the type and intensity of exercise required for effective treatment, and thus the effects of qigong and multicomponent exercise on multiple health outcomes in panic disorder. The aim of this study is to examine the effects of Qigong exercise training and multicomponent exercise training on anxiety-panic, balance, mobility, walking, functional strength, physical activity, sleep quality, fatigue, chronic musculoskeletal pain, quality of life and cognition.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being between the ages of 18-65

Being diagnosed with "panic disorder" by a psychiatrist

Not having another psychiatric illness

Wanting to participate in the research voluntarily and signing the informed consent

Disqualifiers

Having a vision and/or hearing problem that would prevent participation in the study

History of neurological, cardiopulmonary and musculoskeletal system disease that would negatively affect participation in evaluation and treatment

Trial design

Design model

Parallel

Treatments tested in this trial

  • Exercise Training

    Other intervention

    Exercise training for 8 weeks

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Qigong-Baduanjin Exercise Training GroupExperimental treatment 1 intervention
Group B: Multicomponent Exercise (resistance, balance, endurance and cognitive-motor skills) Training GroupExperimental treatment 1 intervention
Group C: Wait List - Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

DSM-5 Panic Disorder Severity Scale

Panic levels will be evaluated with the DSM-5 Panic Disorder Severity Scale. It provides a five-point Likert-type rating (0=never, 1=sometimes, 2=half of the time, 3=most of the time, 4=all of the time). Scores obtained from the scale items determine the severity of panic disorder. The total score for the scale ranges from 0 to 40, with higher scores indicating more severe panic disorder symptoms.

Time frame
change from baseline to 8 weeks
2

State-Trait Anxiety Inventory

State and trait anxiety levels will be assessed with the State-Trait Anxiety Inventory. The State-Trait Anxiety Inventory is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety separately in two forms (STAI-S; STAI-T)-state anxiety and trait anxiety. The scale has 20 state-domain and 20 trait-domain questions. A score of 1 indicates that the situation described in the question does not reflect their personality at all; a score of 4 indicates that the situation described in the question reflects their personality completely. Each form is scored between 20 and 80, with higher scores positively correlated with higher anxiety levels, while lower scores indicate lower anxiety levels. The cutoff score for this scale is 44, with scores of 45 and above indicating higher anxiety levels.

Time frame
change from baseline to 8 weeks

Secondary outcomes

1

Mini-Balance Assessment Systems Test

The Mini-Balance Assessment Systems Test will be used for clinical balance assessment.

Time frame
change from baseline to 8 weeks
2

Functional Walking Assessment

Functional Walking Assessment will be used to assess postural stability and balance during various walking tasks.

Time frame
change from baseline to 8 weeks
3

Activity-Specific Balance Confidence Scale

Activity-Specific Balance Confidence Scale will be used to evaluate functional balance-mobility-walking performance. For each question, the score ranges from 0% (no confidence) to 100% (full confidence). The values across all activities are summed and the average calculated. Measurement results range from 0% to 100%, with a higher average score indicating higher confidence. A score above 80% on this scale indicates that the balance is reliable.

Time frame
change from baseline to 8 weeks
4

5-Repetition Sit-to-Stand Test

The 5-Repetition Sit-to-Stand Test will be used to measure overall stability and functional lower extremity muscle strength.

Time frame
change from baseline to 8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.